Search for: "Mylan, Inc."
Results 1 - 20 of 154
Sorted by Relevance | Sort by Date
21 Oct 6:08 pm
Generic drug maker, Mylan Inc, will pay the U.S government $121 million to settle a civil dispute, started by a whistleblower, involving Medicaid rebates on drug sales
from 2000 to 2004. The dispute called into question whether an authorized generic medicine is subject to the generic rate that Mylan paid on sales from 2000 to 2004, or a higher
innovator rate. Mylan was treating its authorized generics as traditional generics, a ...
24 Aug 9:10 am
... its reporters, Patricia Sabatini and Len Boselovic, have been an aggravation, to put it mildly, to generic drug manufacturer Mylan Inc. for some time. But it looks
like the Post-Gazette's July 26 story written by Sabatini ... issues existed. But another paragraph suggests the real reason for the lawsuit: The sensationalized misuse of the Documents
caused harm to Mylan and its shareholders, evidenced by substantial market volatility, a decrease in its stock price, and the resulting decrease in market ...
24 Oct, 2007 12:46 pm
... issued yesterday, October 23, 2007: Mylan Inc. (NYSE: MYL) today announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a
patent license ... Tablets, the generic version of GSK's Paxil CR®. All litigation between Mylan and GSK relating to Paroxetine HCl ER Tablets will be dismissed with prejudice.
Under ... million for the 12 months ending June 30, 2007, for all three strengths. Mylan was the first company to file an ANDA containing a paragraph IV certification covering
the 12 ...
8 Aug 1:43 am
A Texas law firm is targeting generic drug giant Mylan Inc., along with other pharmaceutical companies, in product liability lawsuits related to the manufacture of pain
patches. The lawsuits involve the powerful painkiller fentanyl, which is applied ... at a time when the Food & Drug Administration has been looking into allegations of compliance
problems at a separate Mylan plant in Morgantown, W.Va. The FDA probe was prompted by a July 26 story in the Pittsburgh Post-Gazette that described how ...
24 Oct, 2008 12:32 am
The following appeared yesterday, October 22, 2008, at Business Week: Mylan Inc. said Wednesday it has been accused of patent infringement by Novartis AG over
Mylan's generic version of the Swiss company's Lescol capsules for treating high cholesterol. Pittsburgh-based Mylan ... this month in U.S. District Court in New Jersey
accusing Mylan and its subsidiary, Mylan Pharmaceuticals Inc., of violating a patent. Mylan's generic version of Lescol is called Fluvastatin. Mylan
said it ...
18 Oct 5:42 pm
... by Mylan Pharmaceuticals Inc. Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma
Ltd. for patent infringement in the [...] Related posts: Merck Wins Singulair Victory Over TevaEarlier today, ... Regarding AndroGel Patent Settlement The Federal Trade Commission has
filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par
Pharmaceutical ...
5 Dec, 2008 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals
Corp., Novartis Corp., and Novartis International AG over a generic version of ... of about $470 million for the 12 months ending September 30, 2008. Novartis initiated the dispute in
June of 2006, when it sued Mylan following Mylan's filing of an ANDA with a Paragraph IV certification seeking approval to market generic letrozole tablets prior to...
17 Jun 5:02 am
... Milford and Susan Decker at Bloomberg: Pfizer Inc., the world's biggest drugmaker, sued rival Mylan Inc. asking a judge to prohibit sales of a generic version
... filed today in Wilmington, Delaware, lawyers for New York-based Pfizer contend a Mylan affiliate has applied to the U.S. Food and Drug Administration for permission ... and
plans to enter the market in November 2011. Pfizer already is suing Apotex Inc. and Teva Pharmaceutical Industries Ltd. to prevent them from selling copies of the medicine ...
5 Jun, 2008 9:39 pm
The following Associated Press item appeared yesterday, June 4, 2008, on CNN Money: Generic drug maker Mylan Inc. said Wednesday it is being sued by Japanese drug maker
Daiichi Sankyo for patent infringement on blood pressure drug Azor. ... Ltd., citing Matrix's application earlier this year with the Food and Drug Administration to sell a generic
version of Azor. Mylan said it believes Matrix is the first company to file an application with a Paragraph IV certification, which is used to challenge an ...
27 Apr, 2008 11:47 pm
... Virginia University [WVU] determined that there was no academic justification for retroactively granting Heather Bresch, the daughter of Gov. Joe Manchin III. The Mylan
connection, as reported by the New York Times, is as follows: Ms. Bresch, 38, works for Mylan Inc. It is the world's third-largest generic drug company and employs 2,000
people in Morgantown, W.Va. The company's chairman, Milan Puskar, is a major campaign contributor to Mr. Manchin, ...
10 Apr 10:58 am
From the April 9, 2009 issue of The Pittsburgh Tribune-Review: Mylan Inc. announced a patent litigation settlement with Schering-Plough concerning its generic version of
the Clarinex allergy medication, a case pending in federal court for 2 1/2 years. Under the settlement, Canonsburg-based Mylan can market its generic Desloratadine tablets in the
5-milligram size in the United States beginning July 1, 2012, with U.S. Food and Drug ...
6 Jan, 2008 10:28 am
... Irene M. Keeley. AstraZeneca Pharmaceuticals LP, et al. v. Mylan Laboratories, Inc., Civil Action No. 1:07-CV-00177. In the action, AstraZeneca ... approval for
rosuvastatin calcium tablets, which is the generic version of Crestor. According to the complaint, Mylan's position before the FDA is that AstraZeneca's patent for Crestor is
invalid and ... litigation, Judge Keeley has denied the motion to dismiss filed by Eliot Disner in Mylan's legal malpractice lawsuit against him. Here is Judge Keeley's ...
20 Aug, 2007 1:30 pm
... West Virginia where it is pending before Chief District Judge Irene M. Keeley. Mylan Laboratories, Inc. v. Eliot G. Disner, Civil Action No. 1:07- ... August 24. This
case is perplexing. First of all, if my math is right, Mylan has paid out and may ultimately owe to the plaintiffs who opted out ... class settlement a total of approximately
$300 million. I don't know how much of that Mylan realistically expects to recover from Disner, assuming that it proves its allegations against him. As I mentioned, ...
19 Aug 6:25 am
... year. The SEC's order is available here. The Perry settlement arose from the failed attempt by Mylan Laboratories, Inc. to acquire King Pharmaceuticals, Inc. in
2004. Perry had a significant ownership stake in King and stood to benefit from the merger, ... was not in Mylan's best interests. Thus, Perry had different, and possibly
inconsistent, interests from those of Mylan's other stockholders. The issue of "empty voting" is part of a larger phenomenon identified by Professors Henry Hu and Bernard ...
27 Oct, 2006 9:43 am
... eligible for 180 days of market exclusivity. The FDA has indicated that the exclusivity will begin to run from the earlier of the commercial launch of the Mylan product or a
final court decision concerning the pending litigation between Pfizer and Mylan. In Ortho-McNeil Pharmaceutical v ... as a matter of law, is independent of the motivations that
led the inventors to the claimed invention." Life Techs., Inc. v. Clontech Lab., Inc., 224 F.3d 1320, 1325 (Fed. Cir. 2000). Rather, § 103 requires that ...
23 Jun, 2008 11:55 am
... initiating a Class 1 nationwide recall of Digitek (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals, Inc. under
a "Bertek" label and by UDL Laboratories, Inc. under a ... lawsuits filed on behalf of people injured by the defective Digitek. There are indications, however, that the FDA
agrees with Mylan as regards accountability in the regulatory arena. The following is taken from "CDER's Compliance Office Highlights Manufacturer Accountability", ...
30 Sep 11:07 am
... , even though diversity of citizenship does not exist. But PG argues that Mylan, which is a Pennsylvania corporation and is the parent of Mylan Pharmaceuticals,
Inc., "has no standing to sue for or recover damages" because the plaintiffs' claims are " ... of all persons delivering the Documents to the Post-Gazette or
Reporter-Defendants." (Emphasis added.) In a footnote, PG describes Mylan's decision to file in state court as a "cynical appeal to local interests [] manifested , for instance,
in the ...
17 Dec, 2008 5:54 am
... No. 4,687,777. The challenges to the '777 patent had been initiated by Defendants-Appellants Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and
UDL Laboratories, Inc. (Mylan) on the one hand, and Defendants-Appellants Alphapharm Pty., Inc. and Genpharm, Inc. (Alphapharm) on the other. Seeking
approval to market a generic version of the antidiabetic agent, 5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}-2,4-thiazolidinedione, ...
10 Jun 9:02 pm
... of the awarded costs. Daiichi owns U.S. Patent No. 5,053,407, which relates to levofloxacin, an antibiotic that Daiichi markets under the trade name Levaquin®. Seeking approval to
market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug
Application (ANDA) with the FDA. In response to Mylan's ANDA filing,...
11 Dec, 2008 8:03 am
... a simple negligence standard but found Alphapharm's filing "baseless." Of Mylan: But Mylan's Rule 30(b)(6) designee testified that no reason ... nothing with respect
to pyridines. We find it unsurprising, therefore, that the district court characterized Mylan's defense of the merits of its Paragraph IV letter as "utterly frivolous."
Separately, eBay/ ... must be read in the context of the entire specification and prosecution history. See Rambus Inc. v. Infineon Techs. AG, 318 F.3d 1081, 1094 (Fed. Cir ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!